Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06057181 · ClinicalTrials.gov registry record

Helix Research Network

A clinical trial of Genetic Predisposition to Disease and Genetics Disease, sponsored by Helix.

Recruiting
Registry status
2,000,000
Enrollment target
14
Study locations

NCT06057181: Recruiting study of Genetic Predisposition to Disease and Genetics Disease, sponsored by Helix.

NCT06057181 is a study of Genetic Predisposition to Disease and Genetics Disease that is actively recruiting participants, run by Helix. The registered enrollment target is 2,000,000 participants, above the 706-participant average among 11 other Genetic Predisposition to Disease trials with a reported enrollment target (283186% higher). The trial reports 14 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06057181, a study of Genetic Predisposition to Disease and Genetics Disease, is actively recruiting participants, sponsored by Helix.

RECRUITING
Registry status
2,000,000 participants
Enrollment target
14
Study locations

Study Summary

The Helix Research Network ("HRN") is a network of academic, public, and/or private healthcare organizations that are committed to advancing medical research and improving human health through large-scale genomics research and acceleration of the integration of genomic and other omics data into clinical care.

Conditions Studied

Genetic Predisposition to Disease Genetics Disease

Interventions

  • GENETIC Exome sequencing

Study Locations (14)

North Carolina

  • Cone Health (Gene Connect) - Burlington
  • WakeMed (PreciselyYou) - Raleigh

Ohio

  • TriHealth (DNA Discovery) - Cincinnati
  • The Ohio State University (Genomic Health) - Columbus

Pennsylvania

  • St. Luke's University Health Network (DNAanswers) - Bethlehem
  • WellSpan Health (The Gene Health Project) - York

Indiana

  • Parkview Health (DNA Insights) - Fort Wayne

Minnesota

  • HealthPartners (myGenetics) - Bloomington

Nebraska

  • Nebraska Medicine - University of Nebraska Medical Center (Genetic Insights Project) - Omaha

Nevada

  • Renown Health (Healthy Nevada Project) - Reno

New York

  • Rochester Regional Health (GenoWell) - Rochester

Trial Details

FieldValue
Enrollment Target 2,000,000 participants
Start Date 2021-09-13
Est. Completion 2036-09-13

Sponsor

Helix

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06057181

The ClinicalTrials.gov registry entry for NCT06057181 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,000,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 706-participant average among 11 other Genetic Predisposition to Disease trials with a reported enrollment target (283186% higher). The listed sponsor is Helix, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Genetic Predisposition to Disease appearing as the primary indexed condition, and to 1 intervention - of which Exome sequencing is the first listed.

NCT06057181 reports 14 study locations spanning 11 distinct geographic areas - top geographies include North Carolina, Ohio, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06057181 about?

NCT06057181 is a clinical study titled "Helix Research Network". The Helix Research Network ("HRN") is a network of academic, public, and/or private healthcare organizations that are committed to advancing medical research and improving human health through large-scale genomics research and acceleration of the integration of genomic and other omics data into clin...

What is the current status of trial NCT06057181?

This trial is currently recruiting. The enrollment target is 2,000,000 participants. The study started on 2021-09-13. Estimated completion is 2036-09-13.

What conditions does trial NCT06057181 study?

This clinical trial studies the following conditions: Genetic Predisposition to Disease, Genetics Disease.

What interventions are being tested in trial NCT06057181?

The interventions under investigation include: Exome sequencing (GENETIC).

Who is sponsoring clinical trial NCT06057181?

This trial is sponsored by Helix, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06057181 being conducted?

This trial has 14 study locations across Indiana, Minnesota, Nebraska, Nevada, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Genetic Predisposition to Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Genetic Predisposition to Disease

All registered trials for this condition

Genetics Disease

All registered trials for this condition

Indiana

All trials with a study site in Indiana

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.